From 2022, the New West Health & Innovation District (HID) in Amsterdam will provide new laboratory and office space for companies in transfusion medicine, immunology, hematology and oncology. The need for office and lab space of these types of companies is great.
The first companies have now established themselves on the HID site in Nieuw West, including Sanagen, Framerapeutics, Zwiers Regulatory Consultancy, BISC Global, the International Plasma and Fractionated Association (IPFA) and Prothya Biosolutions. Founder of the HID, Sanquin, and the municipality of Amsterdam have a demand for more laboratory and office space for the Life Sciences & Health sector.
From 2024, one of the buildings will be equipped with state-of-the-art laboratories.
Law Victor Everhardt (‘Economic Affairs’): “The holder of buildings with a combination of lab and office function is large in the Amsterdam region. The development of new medicines, vaccines and diagnostics & new spaces for research and production in the field of Life Sciences Health. We are therefore supporting this development with a subsidy of 500,000 euros”
Rogier van den Braak, initiator of the HID: “The HID is a location for companies and organizations with a focus on transfusion medicine, hematology, oncology and immunology. The aim of the HID is for parties to reinforce each other, from start-ups to corporates, from commercial single-player to renowned public institutes. With the aim of improving the lives of patients by developing innovative solutions for health problems.”
It will be the first building of the HID in which entrepreneurs can develop into their own laboratories. These entrepreneurs can grow up to the new buildings within the HID.